Clinical trial
A Randomized Study With Loading Dose of Prasugrel Opposed to the Standard Dose of Clopidogrel in Type 2 Diabetic Patients in Acute Coronary Syndrome, Revascularized Through Drug-eluting Stent.
NCT01684813 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study With Loading Dose of Prasugrel Opposed to the Standard Dose of Clopidogrel in Type 2 Diabetic Patients in Acute Coronary Syndrome, Revascularized Through Drug-eluting Stent.
- Lead sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- October 31, 2013
- Enrollment
- 65 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, diabetes mellitus type ii